PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly(l‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer

Vascular disrupting agents (VDAs) have great potential for cancer treatment. Poly(l‐glutamic acid)‐combretastatin A4 conjugate (PLG‐CA4) is a novel class of VDAs. Though it has notable antitumor activity, it can induce host immune responses that promote tumor growth. Here, PLG‐CA4 induces the polari...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Hanjiao, Yu, Haiyang, Sheng, Jiyao, Zhang, Dawei, Shen, Na, Liu, Linlin, Tang, Zhaohui, Chen, Xuesi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662090/
https://www.ncbi.nlm.nih.gov/pubmed/31380170
http://dx.doi.org/10.1002/advs.201900327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662090/
https://www.ncbi.nlm.nih.gov/pubmed/31380170
http://dx.doi.org/10.1002/advs.201900327

Ejemplares similares